327 related articles for article (PubMed ID: 22037217)
21. Frequent genetic and biochemical alterations of the PI 3-K/AKT/PTEN pathway in head and neck squamous cell carcinoma.
Pedrero JM; Carracedo DG; Pinto CM; Zapatero AH; Rodrigo JP; Nieto CS; Gonzalez MV
Int J Cancer; 2005 Mar; 114(2):242-8. PubMed ID: 15543611
[TBL] [Abstract][Full Text] [Related]
22.
Parisotto M; Grelet E; El Bizri R; Dai Y; Terzic J; Eckert D; Gargowitsch L; Bornert JM; Metzger D
J Exp Med; 2018 Jun; 215(6):1749-1763. PubMed ID: 29743291
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of PIK3CA in murine head and neck epithelium drives tumor invasion and metastasis through PDK1 and enhanced TGFβ signaling.
Du L; Chen X; Cao Y; Lu L; Zhang F; Bornstein S; Li Y; Owens P; Malkoski S; Said S; Jin F; Kulesz-Martin M; Gross N; Wang XJ; Lu SL
Oncogene; 2016 Sep; 35(35):4641-52. PubMed ID: 26876212
[TBL] [Abstract][Full Text] [Related]
24. A positive feedback loop involving EGFR/Akt/mTORC1 and IKK/NF-kB regulates head and neck squamous cell carcinoma proliferation.
Li Z; Yang Z; Passaniti A; Lapidus RG; Liu X; Cullen KJ; Dan HC
Oncotarget; 2016 May; 7(22):31892-906. PubMed ID: 26895469
[TBL] [Abstract][Full Text] [Related]
25. Inducible TgfbR1 and Pten deletion in a model of tongue carcinogenesis and chemoprevention.
Lamenza FF; Ryan NM; Upadhaya P; Siddiqui A; Jordanides PP; Springer A; Roth P; Pracha H; Iwenofu OH; Oghumu S
Cancer Gene Ther; 2023 Aug; 30(8):1167-1177. PubMed ID: 37231058
[TBL] [Abstract][Full Text] [Related]
26. DKK3 Overexpression Increases the Malignant Properties of Head and Neck Squamous Cell Carcinoma Cells.
Katase N; Nishimatsu SI; Yamauchi A; Yamamura M; Terada K; Itadani M; Okada N; Hassan NMM; Nagatsuka H; Ikeda T; Nohno T; Fujita S
Oncol Res; 2018 Jan; 26(1):45-58. PubMed ID: 28470144
[TBL] [Abstract][Full Text] [Related]
27. Knockdown of HPIP Inhibits the Proliferation and Invasion of Head-and-Neck Squamous Cell Carcinoma Cells by Regulating PI3K/Akt Signaling Pathway.
Chen Y; Zhao R; Zhao Q; Shao Y; Zhang S
Oncol Res; 2016; 24(3):153-60. PubMed ID: 27458096
[TBL] [Abstract][Full Text] [Related]
28. Hypoxic niches are endowed with a protumorigenic mechanism that supersedes the protective function of PTEN.
Nascimento-Filho CHV; Webber LP; Borgato GB; Goloni-Bertollo EM; Squarize CH; Castilho RM
FASEB J; 2019 Dec; 33(12):13435-13449. PubMed ID: 31560860
[TBL] [Abstract][Full Text] [Related]
29. Alpha-2 Heremans Schmid Glycoprotein (AHSG) modulates signaling pathways in head and neck squamous cell carcinoma cell line SQ20B.
Thompson PD; Sakwe A; Koumangoye R; Yarbrough WG; Ochieng J; Marshall DR
Exp Cell Res; 2014 Feb; 321(2):123-32. PubMed ID: 24332981
[TBL] [Abstract][Full Text] [Related]
30. PTEN expression controls cellular response to cetuximab by mediating PI3K/AKT and RAS/RAF/MAPK downstream signaling in KRAS wild-type, hormone refractory prostate cancer cells.
Bouali S; Chrétien AS; Ramacci C; Rouyer M; Becuwe P; Merlin JL
Oncol Rep; 2009 Mar; 21(3):731-5. PubMed ID: 19212633
[TBL] [Abstract][Full Text] [Related]
31. Akt activation synergizes with Trp53 loss in oral epithelium to produce a novel mouse model for head and neck squamous cell carcinoma.
Moral M; Segrelles C; Lara MF; Martínez-Cruz AB; Lorz C; Santos M; García-Escudero R; Lu J; Kiguchi K; Buitrago A; Costa C; Saiz C; Rodriguez-Peralto JL; Martinez-Tello FJ; Rodriguez-Pinilla M; Sanchez-Cespedes M; Garín M; Grande T; Bravo A; DiGiovanni J; Paramio JM
Cancer Res; 2009 Feb; 69(3):1099-108. PubMed ID: 19176372
[TBL] [Abstract][Full Text] [Related]
32. Co-deleting Pten with Rb in retinal progenitor cells in mice results in fully penetrant bilateral retinoblastomas.
Xie C; Lu H; Nomura A; Hanse EA; Forster CL; Parker JB; Linden MA; Karasch C; Hallstrom TC
Mol Cancer; 2015 Apr; 14():93. PubMed ID: 25907958
[TBL] [Abstract][Full Text] [Related]
33. MEK Inhibitor PD-0325901 Overcomes Resistance to PI3K/mTOR Inhibitor PF-5212384 and Potentiates Antitumor Effects in Human Head and Neck Squamous Cell Carcinoma.
Mohan S; Vander Broek R; Shah S; Eytan DF; Pierce ML; Carlson SG; Coupar JF; Zhang J; Cheng H; Chen Z; Van Waes C
Clin Cancer Res; 2015 Sep; 21(17):3946-56. PubMed ID: 25977343
[TBL] [Abstract][Full Text] [Related]
34. Loss of TP63 Promotes the Metastasis of Head and Neck Squamous Cell Carcinoma by Activating MAPK and STAT3 Signaling.
Lakshmanachetty S; Balaiya V; High WA; Koster MI
Mol Cancer Res; 2019 Jun; 17(6):1279-1293. PubMed ID: 30910837
[TBL] [Abstract][Full Text] [Related]
35. MiRNA-620 promotes TGF-β1-induced proliferation of airway smooth muscle cell through controlling PTEN/AKT signaling pathway.
Chen H; Guo SX; Zhang S; Li XD; Wang H; Li XW
Kaohsiung J Med Sci; 2020 Nov; 36(11):869-877. PubMed ID: 32583575
[TBL] [Abstract][Full Text] [Related]
36. Wnt signaling dynamics in head and neck squamous cell cancer tumor-stroma interactions.
Le PN; Keysar SB; Miller B; Eagles JR; Chimed TS; Reisinger J; Gomez KE; Nieto C; Jackson BC; Somerset HL; Morton JJ; Wang XJ; Jimeno A
Mol Carcinog; 2019 Mar; 58(3):398-410. PubMed ID: 30378175
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of SRC family kinases reduces myeloid-derived suppressor cells in head and neck cancer.
Mao L; Deng WW; Yu GT; Bu LL; Liu JF; Ma SR; Wu L; Kulkarni AB; Zhang WF; Sun ZJ
Int J Cancer; 2017 Mar; 140(5):1173-1185. PubMed ID: 27798955
[TBL] [Abstract][Full Text] [Related]
38. The effect of LKB1 on the PI3K/Akt pathway activation in association with PTEN and PIK3CA in HNC.
Ekizoglu S; Dogan S; Ulker D; Seven D; Gozen ED; Karaman E; Buyru N
Clin Otolaryngol; 2015 Dec; 40(6):622-8. PubMed ID: 25850957
[TBL] [Abstract][Full Text] [Related]
39. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
Al-Dhfyan A; Alhoshani A; Korashy HM
Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
[TBL] [Abstract][Full Text] [Related]
40. TrkB induces EMT and has a key role in invasion of head and neck squamous cell carcinoma.
Kupferman ME; Jiffar T; El-Naggar A; Yilmaz T; Zhou G; Xie T; Feng L; Wang J; Holsinger FC; Yu D; Myers JN
Oncogene; 2010 Apr; 29(14):2047-59. PubMed ID: 20101235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]